secwatch.observer — SEC 8-K summary ====================================== Issuer: ULTRALIFE CORP (ULBI) CIK: 0000875657 Form: 8-K Filed at: 2026-08-07T20:01:29+00:00 Accession: 0001437749-26-026573 Event type: earnings Sentiment: positive Materiality: 0.75 Item codes: 2.02, 9.01 LLM model: deepseek-v4-flash:cloud@v2 Ultralife Q2 EPS $0.15 vs $0.05; record backlog $117.5M, gross margin up 500 bps -------------------------------------------------------------------------------- - Sales $47.9M, down 1.3% YoY; gross margin 28.9% vs 23.9% (incl. $1.1M IEEPA refund). - GAAP EPS $0.15 vs $0.05; adjusted EBITDA $6.1M vs $4.1M. - Backlog $117.5M, record high, up from $115.1M Q1 and $84.5M year ago. - Communications Systems sales up 39.3% to $3.8M; Battery & Energy down 3.7% to $44.2M. - One-time costs $0.9M (litigation for cyber-insurance claim, consulting); 45X tax credit partially offsets interest. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/875657/000143774926026573/0001437749-26-026573-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/875657/000143774926026573/ulbi20260807_8k.htm HTML page: https://secwatch.observer/filing/0001437749-26-026573 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer